Impact Of Cytoterm On Vasomotor Symptoms (VMS) And Quality Of Life (Qol) Impairments In Patients Receiving Hormone Therapy (HT) And Radiotherapy (RT) For Prostate Cancer (Pca). Results Of The ESCULAPE Phase II Study.